Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6% ...

Separately, Haleon will also buy around £230 million worth of its shares from Pfizer at the price set in the share offering, ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

US pharmaceutical giant Pfizer concluded its second sell-down in its consumer healthcare spin-off, Haleon. It raised £2.432bn ...

This summary covers recent developments in health news, from Humana's slumping Medicare plan enrollments impacting future ...

Oil prices jumped and stocks tumbled on Tuesday after Iran fired an estimated 180 missiles at Israel in retaliation for the ...

Health-care CVS Health has spent more than $88 billion in the last half-dozen years to add a major health insurer, a clinic operator and a home-visit provider to its namesake pharmacies, but the ...

Pharmaceutical giant Pfizer Inc. announced on Tuesday that it has reduced its stake in British consumer healthcare company ...

This article summarizes recent significant developments in the health sector, including Johnson & Johnson's investment in a ...

The price of Brent crude jumped to above $75 a barrel having earlier in the day been below $70. Shell rose 2.2% and BP gained ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...